alpha-aminopyridine has been researched along with Lymphoma, T-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, JC; Liu, J; Zhong, L | 1 |
| Cheng, H; Gebrael, JH; Hermanto, U; Mellacheruvu, S; Rosen, NL; Santos-Zabala, ML; Sayegh, MN; Sica, RA | 1 |
| Batchelor, TT; Grommes, C; Nayak, L; Tun, HW | 1 |
| Dong, M; Du, X; Li, ZB; Lu, XP; Newman, MJ; Ning, ZQ; Pan, DS; Shan, S; Wang, XH; Zhang, J | 1 |
2 review(s) available for alpha-aminopyridine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Effective treatment with programmed cell death protein-1 antibody, chidamide and conventional chemotherapy for hepatosplenic γδ T-cell lymphoma: A case report and literature review.
Topics: Aminopyridines; Apoptosis Regulatory Proteins; Benzamides; Humans; Liver Neoplasms; Lymphoma, T-Cell; Receptors, Antigen, T-Cell, gamma-delta | 2022 |
Introduction of novel agents in the treatment of primary CNS lymphoma.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape | 2019 |
2 other study(ies) available for alpha-aminopyridine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Lymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Humans; Lactams; Lymphoma, T-Cell; Meningitis; Pyrazoles | 2022 |
Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
Topics: Acetylation; Aminopyridines; Animals; Benzamides; Cell Growth Processes; Cell Line, Tumor; Cytotoxicity, Immunologic; Female; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Immunity, Cellular; Isoenzymes; K562 Cells; Killer Cells, Natural; Lymphoma, T-Cell; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Xenograft Model Antitumor Assays | 2012 |